Evidence map›Paper›PMID 40780198›Full record

ArticleStem cell reports2025

PML is crucial for neural stem cell differentiation, stress tolerance and mitochondrial integrity.

Syrago Spanou, Takis Makatounakis, Elena Deligianni, Sofia Papanikolaou, Martina Samiotaki, Fabien Moretto, Christoforos Nikolaou, Joseph Papamatheakis, Androniki Kretsovali

Abstract read
In one paragraph

Article in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Syrago SpanouDepartment of Biology, University of Crete, Heraklion, Greece; Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece.
Takis MakatounakisInstitute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece.
Elena DeligianniInstitute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece.
Sofia PapanikolaouInstitute for Bio-Innovation, Biomedical Sciences Research Center "Alexander Fleming", 16672 Vari, Greece.
Martina SamiotakiInstitute for Bio-Innovation, Biomedical Sciences Research Center "Alexander Fleming", 16672 Vari, Greece.
Fabien MorettoInstitute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece; Institute of Biochemistry and Cellular Genetics, UMR5095, CNRS-University of Bordeaux, 33077 Bordeaux, France.
Christoforos NikolaouInstitute for Bio-Innovation, Biomedical Sciences Research Center "Alexander Fleming", 16672 Vari, Greece.
Joseph PapamatheakisDepartment of Biology, University of Crete, Heraklion, Greece; Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece.
Androniki KretsovaliInstitute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece. Electronic address: kretsova@imbb.forth.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor suppressor promyelocytic leukemia protein (PML) has important roles in brain development; however, the molecular and cellular pathways regulated by PML in neuronal cells remain largely unknown. To address this issue, we analyzed gene expression changes caused by loss of PML in neural stem cells. Our findings revealed that PML-deficient cells exhibited increased mTOR (mammalian target of rapamycin) pathway activation and protein translation, as well as impaired autophagy and proteasome activity, resulting in increased formation of aggregates and stress-induced death. Loss of PML disrupted mitochondrial integrity, leading to impaired respiration, membrane potential, morphology, and production of increased reactive oxygen species. These mitochondrial defects were caused by diminished PGC-1α expression and PPARγ (peroxisome proliferator-activated receptor gamma) signaling and could be reversed using a PPAR agonist. Together, our results indicate that PML is a critical regulator of neuronal survival and protection from stress. We propose that enhancing PML expression may offer therapeutic benefits in neurological disorders.

Indexed as

Cell DifferentiationMitochondriaNeural Stem CellsNuclear ProteinsStress, PhysiologicalTranscription FactorsTumor Suppressor ProteinsAnimalsAutophagyHumansMicePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR gammaPromyelocytic Leukemia ProteinReactive Oxygen SpeciesSignal TransductionNuclear ProteinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPml protein, mousePPAR gammaPpargc1a protein, mousePromyelocytic Leukemia ProteinReactive Oxygen SpeciesTOR Serine-Threonine KinasesTranscription FactorsTumor Suppressor Proteinsembryonic neural stem celleNSCmitochondria metabolismperoxisome proliferator-activated receptor gammaperoxisome proliferator-activated receptor gamma coactivator 1-alphaPGC-1αPMLPPARγpromyelocytic leukemia proteinproteomicstranscriptomics

Identifiers

PMID40780198
PMCPMC12447341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.